Nutex Health (NUTX) Q2 FY26 earnings call

Nutex Health delivered a strong financial performance in Q2 FY26, marked by significant net income and adjusted EBITDA growth, despite a revenue decline attributed to prior-year IDR collection adjustments. The company saw robust patient visit growth and improved operational efficiencies, benefiting from favorable federal court rulings and regulatory changes to the IDR process. Management is focused on internalizing real estate development and expanding service lines to drive future growth and shareholder value.